Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 119


Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic Mechanisms.

Leber A, Hontecillas R, Zoccoli-Rodriguez V, Bassaganya-Riera J.

Inflamm Bowel Dis. 2018 Apr 28. doi: 10.1093/ibd/izy167. [Epub ahead of print]


NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.

Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Abedi V, Bassaganya-Riera J.

Front Immunol. 2018 Feb 26;9:363. doi: 10.3389/fimmu.2018.00363. eCollection 2018.


Agents and networks to model the dynamic interactions of intracellular transport.

Mayorga LS, Verma M, Hontecillas R, Hoops S, Bassaganya-Riera J.

Cell Logist. 2017 Nov 29;7(4):e1392401. doi: 10.1080/21592799.2017.1392401. eCollection 2017.


Modulation of Immune Signaling and Metabolism Highlights Host and Fungal Transcriptional Responses in Mouse Models of Invasive Pulmonary Aspergillosis.

Kale SD, Ayubi T, Chung D, Tubau-Juni N, Leber A, Dang HX, Karyala S, Hontecillas R, Lawrence CB, Cramer RA, Bassaganya-Riera J.

Sci Rep. 2017 Dec 6;7(1):17096. doi: 10.1038/s41598-017-17000-1.


Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection.

Leber A, Hontecillas R, Abedi V, Tubau-Juni N, Zoccoli-Rodriguez V, Stewart C, Bassaganya-Riera J.

Artif Intell Med. 2017 May;78:1-13. doi: 10.1016/j.artmed.2017.05.003. Epub 2017 May 9.


Abscisic Acid: A Novel Nutraceutical for Glycemic Control.

Zocchi E, Hontecillas R, Leber A, Einerhand A, Carbo A, Bruzzone S, Tubau-Juni N, Philipson N, Zoccoli-Rodriguez V, Sturla L, Bassaganya-Riera J.

Front Nutr. 2017 Jun 13;4:24. doi: 10.3389/fnut.2017.00024. eCollection 2017. Review.


Novel Screening Tool for Stroke Using Artificial Neural Network.

Abedi V, Goyal N, Tsivgoulis G, Hosseinichimeh N, Hontecillas R, Bassaganya-Riera J, Elijovich L, Metter JE, Alexandrov AW, Liebeskind DS, Alexandrov AV, Zand R.

Stroke. 2017 Jun;48(6):1678-1681. doi: 10.1161/STROKEAHA.117.017033. Epub 2017 Apr 24.


Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.

Leber A, Bassaganya-Riera J, Tubau-Juni N, Zoccoli-Rodriguez V, Lu P, Godfrey V, Kale S, Hontecillas R.

Front Immunol. 2017 Feb 21;8:178. doi: 10.3389/fimmu.2017.00178. eCollection 2017.


Cooperation of Gastric Mononuclear Phagocytes with Helicobacter pylori during Colonization.

Viladomiu M, Bassaganya-Riera J, Tubau-Juni N, Kronsteiner B, Leber A, Philipson CW, Zoccoli-Rodriguez V, Hontecillas R.

J Immunol. 2017 Apr 15;198(8):3195-3204. doi: 10.4049/jimmunol.1601902. Epub 2017 Mar 6.


NLRX1 Regulates Effector and Metabolic Functions of CD4+ T Cells.

Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Hulver M, McMillan R, Eden K, Allen IC, Bassaganya-Riera J.

J Immunol. 2017 Mar 15;198(6):2260-2268. doi: 10.4049/jimmunol.1601547. Epub 2017 Feb 3.


Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa.

Verma M, Erwin S, Abedi V, Hontecillas R, Hoops S, Leber A, Bassaganya-Riera J, Ciupe SM.

PLoS One. 2017 Jan 6;12(1):e0168133. doi: 10.1371/journal.pone.0168133. eCollection 2017.


Solving Immunology?

Vodovotz Y, Xia A, Read EL, Bassaganya-Riera J, Hafler DA, Sontag E, Wang J, Tsang JS, Day JD, Kleinstein SH, Butte AJ, Altman MC, Hammond R, Sealfon SC.

Trends Immunol. 2017 Feb;38(2):116-127. doi: 10.1016/ Epub 2016 Dec 13. Review.


Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection.

Leber A, Bassaganya-Riera J, Tubau-Juni N, Zoccoli-Rodriguez V, Viladomiu M, Abedi V, Lu P, Hontecillas R.

PLoS One. 2016 Dec 9;11(12):e0167440. doi: 10.1371/journal.pone.0167440. eCollection 2016.


An N,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease.

Carbo A, Gandour RD, Hontecillas R, Philipson N, Uren A, Bassaganya-Riera J.

J Med Chem. 2016 Nov 23;59(22):10113-10126. Epub 2016 Nov 15.


Translating nutritional immunology into drug development for inflammatory bowel disease.

Leber A, Hontecillas R, Tubau-Juni N, Bassaganya-Riera J.

Curr Opin Gastroenterol. 2016 Nov;32(6):443-449. Review.


Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

Bissel P, Boes K, Hinckley J, Jortner BS, Magnin-Bissel G, Werre SR, Ehrich M, Carbo A, Philipson C, Hontecillas R, Philipson N, Gandour RD, Bassaganya-Riera J.

Int J Toxicol. 2016 Sep;35(5):521-9. doi: 10.1177/1091581816646356. Epub 2016 May 26.


NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.

Coutermarsh-Ott S, Simmons A, Capria V, LeRoith T, Wilson JE, Heid B, Philipson CW, Qin Q, Hontecillas-Magarzo R, Bassaganya-Riera J, Ting JP, Dervisis N, Allen IC.

Oncotarget. 2016 May 31;7(22):33096-110. doi: 10.18632/oncotarget.8861.


Bistability analyses of CD4+ T follicular helper and regulatory cells during Helicobacter pylori infection.

Leber A, Abedi V, Hontecillas R, Viladomiu M, Hoops S, Ciupe S, Caughman J, Andrew T, Bassaganya-Riera J.

J Theor Biol. 2016 Jun 7;398:74-84. doi: 10.1016/j.jtbi.2016.02.036. Epub 2016 Mar 3.


Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis.

Kronsteiner B, Bassaganya-Riera J, Philipson C, Viladomiu M, Carbo A, Abedi V, Hontecillas R.

Gut Microbes. 2016;7(1):3-21. doi: 10.1080/19490976.2015.1116673. Review.


Modeling-Enabled Systems Nutritional Immunology.

Verma M, Hontecillas R, Abedi V, Leber A, Tubau-Juni N, Philipson C, Carbo A, Bassaganya-Riera J.

Front Nutr. 2016 Feb 16;3:5. doi: 10.3389/fnut.2016.00005. eCollection 2016. Review.

Supplemental Content

Loading ...
Support Center